• Aucun résultat trouvé

COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.

N/A
N/A
Protected

Academic year: 2021

Partager "COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry."

Copied!
4
0
0

Texte intégral

Loading

Figure

TABLE 1 Results of coronavirus disease 2019 (COVID-19) diagnostic testing and treatment of confirmed COVID-19 patients according to severe asthma treatment group

Références

Documents relatifs

The most frequent HRCT features (increased lung volume, inspiratory decreased attenuation, mosaic pattern and expiratory air trapping) showed significantly greater scores in

The three studies that evaluated it (9,10,13) found risk of death with COVID-19 was lower in people with allergic asthma compared to non-allergic asthma; the association

While clinical trials investigating the efficacy of vagus nerve stimulation or nicotine administration in COVID-19 for cholinergic anti-inflammatory pathway activation are

Empirical results with real financial data show the performance and risk, final wealth of the capital growth strategy far more than the equal weight strategy. In order to

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des

To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis (PsA), we evaluated the prevalence of ANA in biologic-na ï ve PsA patients and

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des